Cancer immunotherapy - PDFSEARCH.IO - Document Search Engine

Cancer immunotherapy
Results: 490

#	Item
251	AMENDMENTS AND UPDATES TO HUMAN GENE TRANSFER PROTOCOLS RECOMBINANT DNA ADVISORY COMMITTEE MEETING MARCH 11-12, 1999 September 8, [removed]letter Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-14 14:28:36 Biotechnology Amides Cancer treatments Immunology Allovectin-7 Gene therapy Dacarbazine Immunotherapy Prostate cancer Medicine Biology Melanoma
252	Update on Immunotherapy Trials for HIV and Cancer Protocol #[removed]: CD4-zeta CAR T in HIV Patients Protocol #[removed]: MAGE A3 TCR for Myeloma Protocol #[removed]: MAGE A3 TCR for Melanoma Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-30 15:18:55 Anatomy Immunology Chimeric antigen receptor HIV/AIDS T helper cell CD4 Immunotherapy Peripheral blood mononuclear cell Lymphocyte Immune system T cells Biology
253	Microsoft Word - Indication and Important Safety Information for PROVENGE.docx Add to Reading List Source URL: dendreon.com Language: English - Date: 2012-08-19 21:46:13 Sipuleucel-T Immunotherapy Prostate cancer Medicine Dendreon Cancer vaccines
254	GCC-Targeted Immunotherapy Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 12:04:32 Adjuvant therapy Cancer immunotherapy Colorectal cancer Cancer staging Tumor antigen Chemotherapy Management of cancer Cancer Neoadjuvant therapy Medicine Cancer treatments Immunotherapy
255	ID-LV305: A LENTIVECTOR THERAPEUTIC CANCER VACCINE SAFETY BY DESIGN DECEMBER 05, 2013 Breakthrough Therapeutic Vaccines © Immune Design Corp. The information contained herein is subject to copyright Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-04-28 15:05:04 Anatomy Immunotherapy Cancer immunotherapy DC-SIGN Dendritic cell T cell Medicine Biology Immunology
256	RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting September 12, 2012 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-11-26 15:13:35 Stem cells Cancer treatments Acute leukemia Myeloid leukemia Hematopoietic stem cell transplantation Minimal residual disease Acute myeloid leukemia Immunotherapy Myelodysplastic syndrome Medicine Biology Transplantation medicine
257	RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting June 19, 2012 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-11-26 15:17:35 Cancer treatments Cytokines T cells Gene delivery Gene therapy Chimeric antigen receptor Immunotherapy Cell culture Recombinant DNA Biology Medicine Biotechnology
258	Present The Damon Runyon Cancer Research Foundation Clinical Investigator Symposium Monday, April 27, 2009 Add to Reading List Source URL: www.damonrunyon.org Language: English - Date: 2013-08-07 07:09:37 Cancer research Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance Targeted therapy Prostate cancer Immunotherapy Indiana University School of Medicine Tata Memorial Centre Medicine Oncology Cancer organizations
259	T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Brentjens/Sadelain Memorial Sloan Kettering Cancer Center Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:15:08 T cells Lymphoma Immunology Mantle cell lymphoma B-cell chronic lymphocytic leukemia Chimeric antigen receptor Immunotherapy Hematopoietic stem cell transplantation Cancer immunotherapy Medicine Lymphocytic leukemia Immune system
260	Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:32:16 CD20 Immunotherapy Cancer immunotherapy Ofatumumab Medicine Lymphoma Mantle cell lymphoma

UPDATE